Copy Link Print Information

Evrisiran

Evrisiran is a prekallikrein synthesis reducer that has been studied for its potential use in hereditary angioedema.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • No. CAS: 3110420-82-8
  • Fòrmula: C498H665F8N162O313P43S8
  • Peso molecular:15668.86
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Evrisiran Chemical Structure
    Evrisiran Chemical Structure
No. CAS: 3110420-82-8
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Ver todos los productos específicos de isoformas Kallikrein

More

Keywords

MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Evrisiran Chemical Structure
    Evrisiran Chemical Structure RNA, ([1′-de(6-amino-9H-purin-9-yl)]A-(5′→5′)-sp-Um-Gm-Um-Cm-Am-Gm-Um-Um-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)A-Cm-Um-Um-Am-Um-Um-Cm-sp-Am-(3′→3′)-sp-[1′-de(6-amino-9H-purin-9-yl)]A), 3′-[O-[1-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-6,10-bis[2-[[2-[2-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]-2-oxoethyl]-1,5,12-trioxo-16-oxa-6,10,13-triazaoctadec-1-yl]-4-piperidinyl] hydrogen phosphorothioate], complex with RNA (Um-[P(R)]-sp-(2′-deoxy-2′-fluoro)G-sp-Am-Am-Um-Am-(2′-deoxy-2′-fluoro)A-Gm-Um-Gm-Am-(2′-deoxy-2′-fluoro)A-Am-(2′-deoxy-2′-fluoro)A-Am-(2′-deoxy-2′-fluoro)C-Um-Gm-Am-sp-Cm-sp-Am) (1:1)
    1/16
  • RNA, ([1′-de(6-amino-9H-purin-9-yl)]A-(5′→5′)-sp-Um-Gm-Um-Cm-Am-Gm-Um-Um-(2′-deoxy-2′-fluoro)U-Um-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)A-Cm-Um-Um-Am-Um-Um-Cm-sp-Am-(3′→3′)-sp-[1′-de(6-amino-9H-purin-9-yl)]A), 3′-[O-[1-[18-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-6,10-bis[2-[[2-[2-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]-2-oxoethyl]-1,5,12-trioxo-16-oxa-6,10,13-triazaoctadec-1-yl]-4-piperidinyl] hydrogen phosphorothioate], complex with RNA (Um-[P(R)]-sp-(2′-deoxy-2′-fluoro)G-sp-Am-Am-Um-Am-(2′-deoxy-2′-fluoro)A-Gm-Um-Gm-Am-(2′-deoxy-2′-fluoro)A-Am-(2′-deoxy-2′-fluoro)A-Am-(2′-deoxy-2′-fluoro)C-Um-Gm-Am-sp-Cm-sp-Am) (1:1)